Publication | Closed Access
Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib
68
Citations
32
References
2019
Year
GliomaMedicinePathologyNerve Growth FactorHead And Neck CancerConfers ResistanceNeck OncologyOncologyRadiation OncologyTumor MicroenvironmentTumor BiologyCancer GrowthEgfr Inhibitor Erlotinib
| Year | Citations | |
|---|---|---|
Page 1
Page 1